Teva ADR earnings beat, Revenue misses in Q1

  • Investing.com
Teva ADR earnings beat, Revenue misses in Q1

Investing.com - Teva ADR reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.

Teva ADR announced earnings per share of $0.55 on revenue of $3.66B. Analysts polled by Investing.com anticipated EPS of $0.5491 on revenue of $3.74B.

Teva ADR shares are up 6.49% from the beginning of the year and are trading at $8.53 , down-from-52-week-high.They are outperforming the EUR/USD which is down 0% year to date.

Teva ADR follows other major Healthcare sector earnings this month

Teva ADR's report follows an earnings beat by UnitedHealth on Thursday, April 14, 2022, who reported EPS of $5.49 on revenue of $80.15B, compared to forecasts EPS of $5.36 on revenue of $78.73B.

J&J had beat expectations on Tuesday, April 19, 2022 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles